Please login to the form below

Not currently logged in
Email:
Password:

Aptiv

This page shows the latest Aptiv news and features for those working in and with pharma, biotech and healthcare.

Icon boost medical device trial capability with Aptiv acquisition

Icon boost medical device trial capability with Aptiv acquisition. Deal will also enhance the CRO's position inadaptive trials and in Japan. ... Dublin-based contract research organisation Icon has acquired Aptiv Solutions for $143.5m, boosts its

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Mallinckrodt, Ranbaxy Laboratories/ Sun Pharmaceuticals; Silom Medical Company/ Actavis), Pharmaceuticals/Biologics (Furiex/ Forest Laboratories, Andromeda Biotech/ Hyperion Therapeutics), OTC (Insight Pharmaceuticals/ Prestige Brands), Diagnostics

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics